Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Terry Colip
Person

Terry Colip

Overview

Edit Overview Section
Number of Founded Organizations 2
CB Rank (Person) 251,708
Terry Colip is the Founder, CEO & CFO of Cell Theranostics. Terry Colip attended New York University.

Jobs

Edit Jobs Section
Number of Current Jobs 2
Terry Colip has 2 current jobs as Founder, CEO & CFO at Cell Theranostics and Founder, Managing Member & CFO at Cell Point.

Related Hubs

Edit Related Hubs Section
Hub Name  
CB Rank (Hub)  
Closed Biotechnology Companies Logo
Closed Biotechnology Companies
13,240
Closed Health Care Companies (Top 10K) Logo
Closed Health Care Companies (Top 10K)
10,194
Closed Consulting Companies (Top 10K) Logo
Closed Consulting Companies (Top 10K)
13,450
Closed Western US Health Care Companies Logo
Closed Western US Health Care Companies
21,058
Closed Greater Denver Area Companies Logo
Closed Greater Denver Area Companies
25,451
Closed United States Health Care Companies (Top 10K) Logo
Closed United States Health Care Companies (Top 10K)
6,226
Closed United States Consulting Companies Logo
Closed United States Consulting Companies
8,903
Closed Western US Biotechnology Companies Logo
Closed Western US Biotechnology Companies
29,783
Closed Colorado Companies Logo
Closed Colorado Companies
22,581
Closed United States Biotechnology Companies Logo
Closed United States Biotechnology Companies
12,022

Education

Edit Education Section
Terry Colip studied at University of Wisconsin-Madison and  New York University.

Recent News and Activity

Edit Recent News and Activity Section
Number of News Articles 24
News•Mar 29, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 29, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 29, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 6, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 6, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 6, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 9, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 9, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 9, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 18, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
View All
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(b82cf0e 1)
|